258 related articles for article (PubMed ID: 31679692)
21. Inhibition of Contractile Function in Human Joint Capsule Myofibroblasts by Targeting the TGF-β1 and PDGF Pathways.
Mattyasovszky SG; Wollstädter J; Martin A; Ritz U; Baranowski A; Ossendorf C; Rommens PM; Hofmann A
PLoS One; 2016; 11(1):e0145948. PubMed ID: 26730954
[TBL] [Abstract][Full Text] [Related]
22. Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars.
Lapthorn AR; Ilg MM; Dziewulski P; Cellek S
Eur J Pharmacol; 2024 Mar; 967():176369. PubMed ID: 38325796
[TBL] [Abstract][Full Text] [Related]
23. Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast.
Hinz B
Proc Am Thorac Soc; 2012 Jul; 9(3):137-47. PubMed ID: 22802288
[TBL] [Abstract][Full Text] [Related]
24. Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells.
Molina-Molina M; Machahua-Huamani C; Vicens-Zygmunt V; Llatjós R; Escobar I; Sala-Llinas E; Luburich-Hernaiz P; Dorca J; Montes-Worboys A
BMC Pulm Med; 2018 Apr; 18(1):63. PubMed ID: 29703175
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
26. The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling.
Shinde AV; Humeres C; Frangogiannis NG
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):298-309. PubMed ID: 27825850
[TBL] [Abstract][Full Text] [Related]
27. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
[TBL] [Abstract][Full Text] [Related]
28. The altered mechanical phenotype of fetal fibroblasts hinders myofibroblast differentiation.
Jerrell RJ; Leih MJ; Parekh A
Wound Repair Regen; 2019 Jan; 27(1):29-38. PubMed ID: 30315715
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
30. Effect of Botulinum Toxin Type A on Differentiation of Fibroblasts Derived from Scar Tissue.
Jeong HS; Lee BH; Sung HM; Park SY; Ahn DK; Jung MS; Suh IS
Plast Reconstr Surg; 2015 Aug; 136(2):171e-178e. PubMed ID: 26218391
[TBL] [Abstract][Full Text] [Related]
31. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
Jin J; Togo S; Kadoya K; Tulafu M; Namba Y; Iwai M; Watanabe J; Nagahama K; Okabe T; Hidayat M; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Sasaki S; Tominaga S; Takahashi K
Respir Res; 2019 Jun; 20(1):119. PubMed ID: 31185973
[TBL] [Abstract][Full Text] [Related]
32. Targeted killing of myofibroblasts by biosurfactant di-rhamnolipid suggests a therapy against scar formation.
Shen C; Jiang L; Shao H; You C; Zhang G; Ding S; Bian T; Han C; Meng Q
Sci Rep; 2016 Nov; 6():37553. PubMed ID: 27901027
[TBL] [Abstract][Full Text] [Related]
33. Loss of LRP1 promotes acquisition of contractile-myofibroblast phenotype and release of active TGF-β1 from ECM stores.
Schnieder J; Mamazhakypov A; Birnhuber A; Wilhelm J; Kwapiszewska G; Ruppert C; Markart P; Wujak L; Rubio K; Barreto G; Schaefer L; Wygrecka M
Matrix Biol; 2020 Jun; 88():69-88. PubMed ID: 31841706
[TBL] [Abstract][Full Text] [Related]
34. Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-beta1 autocrine loop.
Dabiri G; Tumbarello DA; Turner CE; Van de Water L
J Invest Dermatol; 2008 Oct; 128(10):2518-25. PubMed ID: 18401422
[TBL] [Abstract][Full Text] [Related]
35. A story of fibers and stress: Matrix-embedded signals for fibroblast activation in the skin.
Sawant M; Hinz B; Schönborn K; Zeinert I; Eckes B; Krieg T; Schuster R
Wound Repair Regen; 2021 Jul; 29(4):515-530. PubMed ID: 34081361
[TBL] [Abstract][Full Text] [Related]
36. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
[TBL] [Abstract][Full Text] [Related]
37. Arsenic trioxide inhibits the differentiation of fibroblasts to myofibroblasts through nuclear factor erythroid 2-like 2 (NFE2L2) protein and the Smad2/3 pathway.
Zhong L; Hao H; Chen D; Hou Q; Zhu Z; He W; Sun S; Sun M; Li M; Fu X
J Cell Physiol; 2019 Mar; 234(3):2606-2617. PubMed ID: 30317545
[TBL] [Abstract][Full Text] [Related]
38. In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion.
Shi Q; Liu X; Bai Y; Cui C; Li J; Li Y; Hu S; Wei Y
PLoS One; 2011; 6(11):e28134. PubMed ID: 22132230
[TBL] [Abstract][Full Text] [Related]
39. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P
Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548
[TBL] [Abstract][Full Text] [Related]
40. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
